Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?

Affiliations

• ¹ Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine & Health, University of New South Wales, Sydney, Australia.
• ² Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia.
• ³ School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, University of New South Wales, Sydney, Australia.
• ⁴ The George Institute for Global Health, University of New South Wales, Sydney, Australia.
• ⁵ Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia.
• ⁶ Faculty of Medicine and Health, The University of Sydney, Australia.
• ⁷ Department of Diabetes and Endocrinology, St. Vincent's Hospital, Sydney, Australia.
• ⁸ Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, Australia.
• ⁹ Department of Cardiology, Concord Repatriation General Hospital, Sydney, Australia.